Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230054 | PMC |
| http://dx.doi.org/10.3748/wjg.v30.i24.3120 | DOI Listing |
Publication Analysis
Top Keywords
immune checkpoint
8
managing immune
4
checkpoint inhibitor-associated
4
inhibitor-associated gastritis
4
gastritis insights
4
insights strategies
4
strategies immune
4
checkpoint inhibitors
4
inhibitors icis
4
icis effectiveness
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!